Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-cell integration reveals metaplasia in inflammatory gut diseases.
Oliver AJ, Huang N, Bartolome-Casado R, Li R, Koplev S, Nilsen HR, Moy M, Cakir B, Polanski K, Gudiño V, Melón-Ardanaz E, Sumanaweera D, Dimitrov D, Milchsack LM, FitzPatrick MEB, Provine NM, Boccacino JM, Dann E, Predeus AV, To K, Prete M, Chapman JA, Masi AC, Stephenson E, Engelbert J, Lobentanzer S, Perera S, Richardson L, Kapuge R, Wilbrey-Clark A, Semprich CI, Ellams S, Tudor C, Joseph P, Garrido-Trigo A, Corraliza AM, Oliver TRW, Hook CE, James KR, Mahbubani KT, Saeb-Parsy K, Zilbauer M, Saez-Rodriguez J, Høivik ML, Bækkevold ES, Stewart CJ, Berrington JE, Meyer KB, Klenerman P, Salas A, Haniffa M, Jahnsen FL, Elmentaite R, Teichmann SA. Oliver AJ, et al. Among authors: hoivik ml. Nature. 2024 Nov;635(8039):699-707. doi: 10.1038/s41586-024-07571-1. Epub 2024 Nov 20. Nature. 2024. PMID: 39567783 Free PMC article.
Fatigue in patients with inflammatory bowel disease in remission one year after diagnosis (the IBSEN III study).
Holten KA, Bernklev T, Opheim R, Olsen BC, Detlie TE, Strande V, Ricanek P, Boyar R, Bengtson MB, Aabrekk TB, Asak Ø, Frigstad SO, Kristensen VA, Hagen M, Henriksen M, Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP. Holten KA, et al. Among authors: hoivik ml. J Crohns Colitis. 2024 Nov 11:jjae170. doi: 10.1093/ecco-jcc/jjae170. Online ahead of print. J Crohns Colitis. 2024. PMID: 39527064
Sex and gender in inflammatory bowel disease outcomes and research.
Andersen V, Pingel J, Søfelt HL, Hikmat Z, Johansson M, Pedersen VS, Bertelsen B, Carlsson A, Lindh M, Svavarsdóttir E, Repsilber D, Joergensen MT, Christensen R, Fejrskov A, Füchtbauer JD, Kjeldsen J, Jensen MD, Aalykke C, Rejler M, Høivik ML, Davidsdottir L, Carlson M, Halfvarson J, Zachariassen HH, Petersen LB, Myers ES. Andersen V, et al. Among authors: hoivik ml. Lancet Gastroenterol Hepatol. 2024 Nov;9(11):1041-1051. doi: 10.1016/S2468-1253(24)00159-6. Lancet Gastroenterol Hepatol. 2024. PMID: 39395438 Review.
Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort.
Strande V, Lund C, Hagen M, Bengtson MB, Cetinkaya RB, Detlie TE, Frigstad SO, Høie O, Medhus AW, Henriksen M, Aass Holten KI, Hovde Ø, Huppertz-Hauss G, Johansen I, Olsen BC, Opheim R, Ricanek P, Torp R, Tønnessen T, Vatn S, Aabrekk TB, Høivik ML, Kristensen VA. Strande V, et al. Among authors: hoivik ml. Aliment Pharmacol Ther. 2024 Aug;60(3):357-368. doi: 10.1111/apt.18097. Epub 2024 Jun 4. Aliment Pharmacol Ther. 2024. PMID: 38837289
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
Salihovic S, Nyström N, Mathisen CB, Kruse R, Olbjørn C, Andersen S, Noble AJ, Dorn-Rasmussen M, Bazov I, Perminow G, Opheim R, Detlie TE, Huppertz-Hauss G, Hedin CRH, Carlson M, Öhman L, Magnusson MK, Keita ÅV, Söderholm JD, D'Amato M, Orešič M, Wewer V, Satsangi J, Lindqvist CM, Burisch J, Uhlig HH, Repsilber D, Hyötyläinen T, Høivik ML, Halfvarson J. Salihovic S, et al. Among authors: hoivik ml. Nat Commun. 2024 Jun 3;15(1):4567. doi: 10.1038/s41467-024-48763-7. Nat Commun. 2024. PMID: 38830848 Free PMC article.
Novel biomarker profiles to improve individual diagnosis and prognosis in patients with suspected inflammatory bowel disease: protocol for the Nordic inception cohort study (NORDTREAT).
Fejrskov A, Füchtbauer JD, Davíðsdóttir LG, Halfvarson J, Høivik ML, Jensen MD, Mortensen JH, Nielsen LN, Rejler M, Repsilber D, Söderholm JD, Aalykke C, Andersen V, Christensen R, Kjeldsen J. Fejrskov A, et al. Among authors: hoivik ml. BMJ Open. 2024 May 15;14(5):e083144. doi: 10.1136/bmjopen-2023-083144. BMJ Open. 2024. PMID: 38754881 Free PMC article.
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study.
Wiken TH, Høivik ML, Anisdahl K, Buer L, Warren DJ, Bolstad N, Hagen M, Moum BA, Medhus AW. Wiken TH, et al. Among authors: hoivik ml. Crohns Colitis 360. 2024 Feb 26;6(1):otae013. doi: 10.1093/crocol/otae013. eCollection 2024 Jan. Crohns Colitis 360. 2024. PMID: 38544907 Free PMC article.
Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study.
Zerouga I, Valeur J, Sommer C, Cvancarova Småstuen M, Medhus AW, Lund C, Johansen I, Cetinkaya RB, Bengtson MB, Torp R, Hovde Ø, Huppertz-Hauss G, Detlie TE, Aabrekk TB, Ricanek P, Frigstad SO, Hopstock LA, Opheim R, Kristensen VA, Høivik ML, Hauger Carlsen M, Aas AM. Zerouga I, et al. Among authors: hoivik ml. Scand J Gastroenterol. 2024 Jun;59(6):652-660. doi: 10.1080/00365521.2024.2313056. Epub 2024 Feb 15. Scand J Gastroenterol. 2024. PMID: 38356408
60 results